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Stingless bees produce geopropolis, which is popularly described for its medicinal properties, but for which few scientific studies
have demonstrated pharmacological effects. The objective of this study was to investigate the chemical composition of the
geopropolis of Melipona quadrifasciata anthidioides and to evaluate its antioxidant, antimutagenic, anti-inflammatory, and
antimicrobial activities. The composition of the hydroethanolic extract of geopropolis (HEG) included di- and trigalloyl and
phenylpropanyl heteroside derivatives, flavanones, diterpenes, and triterpenes. HEG showed antioxidant action via the direct
capture of free radicals and by inhibiting the levels of oxidative hemolysis and malondialdehyde in human erythrocytes under
oxidative stress. HEG also reduced the frequency of gene conversion and the number of mutant colonies of S. cerevisiae. The
anti-inflammatory action of HEG was demonstrated by the inhibition of hyaluronidase enzyme activity. In addition, HEG
induced cell death in all evaluated gram-positive bacteria, gram-negative bacteria, and yeasts, including clinical isolates
with antimicrobial drug resistance. Collectively, these results demonstrate the potential of M. q. anthidioides geopropolis
for the prevention and treatment of various diseases related to oxidative stress, mutagenesis, inflammatory processes,
and microbial infections.
1. Introduction
Geopropolis is produced by stingless bees (Hymenoptera,
Apidae, and Meliponinae) [1] from a mixture of wax, pollen,
and the mandibular secretions of bees together with plant
resins and the addition of soil, which characterizes and differ-
entiates this material [2, 3]. Geopropolis is deposited in the
hive to seal cracks, delimit the cavities where bees reside,
and prevent excessive air entry [4].
Analyses of the chemical compositions of geopropolis
samples produced by different species of bees have dem-
onstrated the complexity of this natural product, which
contains phenolic compounds such as benzophenones
[5], phenolic acids, hydrolysable tannins, and flavonoids
[1, 6, 7], in addition to terpenes and long-chain fatty
acids [8, 9].
The compounds found in geopropolis are likely
responsible for the biological activities that have been
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described in several studies, including antimicrobial
[7, 10, 11], anti-inflammatory [2, 12, 13], antinociceptive
[14], gastroprotective [15], antioxidant [1, 6, 16], antiprolif-
erative [5, 11], antimutagenic [7], and cytotoxic [17, 18]
activities.
Among stingless bee species, Melipona quadrifasciata
Lepeletier, 1836, popularly known as mandaçaia, is found
in much of the Brazilian territory and is subdivided into
two subspecies, M. quadrifasciata quadrifasciata and M.
quadrifasciata anthidioides [19, 20], which are well described
in the literature with respect to development and genetic
diversity [19, 21–23]. However, studies examining the
chemical composition and therapeutic properties of the
natural products produced by these subspecies, such as
honey, propolis, and geopropolis, remain scarce.
Kujumgiev et al. [24] described the presence of aromatic
acids and di- and triterpene in the propolis produced by
M. q. anthidioides and revealed its antimicrobial action
against Staphylococcus aureus, Escherichia coli, and Candida
albicans. Velikova et al. [25] attributed the inhibition of
S. aureus by the propolis of M. q. anthidioides to the pres-
ence of the diterpene kaurenoic acid. Recently, Bonamigo
et al. [26] described the presence of several other compounds
in the propolis of this bee subspecies, such as stigmasterol,
taraxasterol, vanillic acid, caffeic acid, quercetin, luteolin,
and apigenin, and demonstrated its antioxidant and
cytotoxic action.
With respect to the geopropolis of this subspecies, only
Bankova et al. [8] investigated its chemical composition,
demonstrating the presence of compounds such as palmitic
acid, oleic acid, benzoic acid, cinnamic acid, vanillin, and
coniferaldehyde. In this context, the objective of this study
was to determine the chemical composition of the
hydroethanolic extract of the geopropolis produced by the
stingless bee M. q. anthidioides, found in the state of Mato
Grosso do Sul, Brazil, and to examine its antioxidant, anti-
mutagenic, anti-inflammatory, and antimicrobial activities.
2. Materials and Methods
2.1. Collection of Geopropolis Samples. Samples of M. q.
anthidioides bee geopropolis were collected at the geographic
coordinates 22°13′12″S and 54°49′2″W in the state of Mato
Grosso do Sul, which is in the Central-West region of Brazil.
Samples were stored at −20°C until analysis.
2.2. Preparation of the Hydroethanolic Extract of Geopropolis.
The hydroethanolic extract of geopropolis (HEG) was pre-
pared from 80 g of geopropolis and 240mL of 70% ethanol.
The mixture was continuously stirred (165 rpm) for 24 h at
room temperature before being filtered. The extract was then
concentrated in a rotary evaporator (Gehaka, São Paulo, SP,
Brazil) at 40°C and lyophilized to obtain a dried extract.
The yield was 4.8%, and the material was stored in the dark
at −20°C.
2.3. Determination of Phenolic Compounds and Flavonoids.
The concentration of phenolic compounds in HEG was
determined by the Folin-Ciocalteu colorimetric method
[27]. To this end, 0.5mL of extract (100μg/mL) was added
to 2.5mL of the Folin-Ciocalteu reagent and 2mL of sodium
carbonate solution (Na2CO3). The mixture was incubated
for 2 h at room temperature in the dark before its
absorbance was measured at 760 nm in a spectrophotometer
(PG Instruments Limited, Leicestershire, UK). Gallic acid
(0.4–11μg/mL) was used as the standard to produce the
calibration curve. The average of three readings was used
to determine the content of phenolic compounds, expressed
as mg of gallic acid equivalents per gram of extract
(mg GAE/g extract).
The concentration of flavonoids was determined using
the method described by Liberio et al. [2] with minor
modifications. Specifically, 0.5mL of extract (100μg/mL)
was added to 4.5mL of methanolic solution of 2% aluminum
chloride hexahydrate (AlCl3·6H2O). The mixture was
incubated for 30min at room temperature in the dark
before its absorbance was measured at 415 nm in a spec-
trophotometer (PG Instruments Limited, Leicestershire,
UK). Quercetin (0.4–11μg/mL) was used as the standard
to produce the calibration curve. The mean of three
readings was used to determine the flavonoid content,
expressed as mg of quercetin equivalent per gram of extract
(mg QE/g extract).
2.4. Analysis of HEG by High-Performance Liquid
Chromatography Coupled to a Diode Array Detector and
Tandem Mass Spectrometry (HPLC-DAD-MS/MS). Five
microliters of HEG (1mg/mL) was injected into an LC-
20AD ultrafast liquid chromatograph (UFLC) (Shimadzu)
connected in line with a diode array detector (DAD) (240–
800 nm) and a mass spectrometer with electrospray ioniza-
tion (ESI) and a quadrupole time-of-flight (QTOF) analyzer
(120–1200Da; micrOTOF-Q III, Bruker Daltonics). It was
equipped with a C-18 Kinetex column (150mm× 2.2mm
inner diameter, 2.6μm) with an oven temperature of 50°C.
The mobile phase consisted of deionized water (A) and
acetonitrile (B), both containing 0.1% formic acid, with the
following gradient: 0–8min, 3% B; 8–30min, 3–25% B; and
30–60min, 25–80% B. The gradient was followed by washing
and reconditioning of the column (8min). The flow rate was
0.3mL/min.
2.5. Antioxidant Activity Assays
2.5.1. DPPH• Free Radical Capture. The 2,2-diphenyl-1-
picrylhydrazyl (DPPH) radical-scavenging activity of the
geopropolis extract was evaluated according to the method
described by D. Gupta and R. K. Gupta [28] with modifica-
tions. Specifically, 200μL of HEG solubilized in 80% ethanol
(0.1–200μg/mL) was mixed with 1800μL of the DPPH•
solution (0.11mM). The mixture was homogenized and
incubated for 30min at room temperature in the dark before
its absorbance was measured at 517nm in a spectrophotom-
eter (PG Instruments Limited, Leicestershire, UK). Ascorbic
acid and butylated hydroxytoluene (BHT) were used as
reference antioxidants. As a negative control, 80% ethanol
alone was incubated with DPPH• solution. Three indepen-
dent experiments were performed in duplicate. The percent
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inhibition relative to the negative control was calculated
using the following:
DPPH• inhibition % =
1 −Abssample
Abscontrol
× 100 1
2.5.2. ABTS•+ Free Radical Scavenging. The antioxidant
capacity of HEG was also evaluated by the method described
by Re et al. [29], in which 2,2′-azinobis(3-ethylbenzthiazo-
line-6-sulfonic acid) (ABTS) free radical-scavenging activity
is examined. The ABTS•+ radical was formed by mixing
5mL of the ABTS solution (7mM) with 88μL of potassium
persulfate solution (140mM). The mixture was incubated
for 12–16 h at room temperature in the dark before the
ABTS•+ radical was diluted in absolute ethanol until it
reached an absorbance of 0.70± 0.05 at 734nm in a spec-
trophotometer (PG Instruments Limited, Leicestershire,
UK). Next, 20μL of HEG solubilized in 80% ethanol
(0.1–200μg/mL) was mixed with 1980μL of the ABTS•+ rad-
ical. The mixture was incubated for 6min, and its absorbance
was then measured at 734 nm. Ascorbic acid and BHT were
used as positive controls. As a negative control, 80% ethanol
alone was incubated with the ABTS•+ radical. Two indepen-
dent experiments were performed in triplicate. The percent
inhibition of the ABTS•+ radical relative to the negative
control was calculated using the following:
ABTS•+ inhibition % =
Abscontrol −Abssample
Abscontrol
× 100 2
2.5.3. Inhibition of Oxidative Hemolysis and Lipid
Peroxidation in Human Erythrocytes. The procedures
performed were approved by the Ethics Committee of the
University Center of Grande Dourados (Centro Universi-
tário da Grande Dourados (UNIGRAN)), Brazil (CEP num-
ber 123/12). The assays were performed as described by
Campos et al. [30].
(1) Preparation of Erythrocyte Suspensions. For the hemolysis
inhibition and malondialdehyde assays, 20mL of peripheral
blood was collected from healthy donors and packed in a
tube containing sodium citrate. The blood was centrifuged
at 2000 rpm for 10min, and the plasma and leukocyte layers
were removed. The erythrocytes were washed with 0.9%
sodium chloride (NaCl), and a 10% erythrocyte suspension
in 0.9% NaCl was further diluted to yield a final erythrocyte
concentration of 2.5% for the experiments.
(2) Hemolytic Activity and Inhibition of Oxidative Hemolysis.
To investigate whether HEG promotes hemolysis in erythro-
cytes, erythrocyte samples were preincubated at 37°C for
30min in the presence of different concentrations of HEG
(5–75μg/mL); 0.9% NaCl solution was then added, and the
mixture was incubated for 240min with periodic homogeni-
zation. The ability of HEG to inhibit oxidative hemolysis was
assessed after preincubation of the extract (5–75μg/mL) with
the erythrocytes at 37°C for 30min; the oxidizing agent 2,2′
-azobis(2-amidinopropane)dihydrochloride (AAPH; 50mM)
was then added, and the mixture was incubated for 240min
with periodic homogenization. Protection against hemolysis
was evaluated after 120, 180, and 240min of incubation.
Hemolysis was assayed by centrifuging the samples at
1500 rpm for 10min and then reading the absorbance of the
supernatant at 540nm in a spectrophotometer (PG Instru-
ments Limited, Leicestershire, UK). The ascorbic acid control
was maintained under the same conditions in both assays. As
a solvent control, the erythrocytes were incubatedwith ethanol
at a final concentration of 1%. Three independent experiments
were conducted in duplicate. The percentage of hemolysis was
calculated using the following formula, where A is the absor-
bance of the sample and B is the total hemolysis (erythrocytes
incubated with distilled water).
Inhibition of hemolysis % = A
B
× 100 3
(3) Quantification of Malondialdehyde (MDA). To examine
the ability of HEG to protect erythrocytes against lipid perox-
idation, the levels of MDA, a byproduct of lipid peroxidation,
were quantified. HEG (5–75μg/mL) was preincubated with
an erythrocyte suspension at 37°C for 30min; the oxidizing
agent AAPH (50mM) was then added, and the mixture was
incubated for 240min with periodic homogenization. After
this period, the samples were centrifuged at 1500 rpm for
10min, and 500μL aliquots of the supernatant was trans-
ferred to tubes containing 1mL of 10nM thiobarbituric acid
(TBA) solubilized in monosodium potassium phosphate
buffer (75mM) at pH2.5. As an MDA standard, 500μL of
20mM MDA solution was added to 1mL of TBA. The
samples were incubated at 96°C for 45min before being
cooled in an ice bath; 4mL of n-butyl alcohol was then added,
and the mixture was centrifuged at 3000 rpm for 5min. The
absorbance of the supernatant was read at 540nm in a
spectrophotometer (PG Instruments Limited, Leicestershire,
UK). The ascorbic acid control was maintained under the
same conditions. As a solvent control, the erythrocytes were
incubated with ethanol at a final concentration of 1%. Three
independent experiments were conducted in duplicate. MDA
levels are expressed as nM/mL and were obtained using
the following:
MDA= Abssample ×
20 × 220 32
AbsMDA standard
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2.6. Antimutagenic Activity. The antimutagenic activity of
HEG was determined using Saccharomyces cerevisiae cells
(D7 diploid strain of ATCC 201137) according to the method
of Pascoal et al. [31]. Before each experiment, S. cerevisiae
strains (MATa/MATa, ade2-40/ade 2-119, trp 5-12/trp 5-27,
and ILV 1-92/ILV 1-92) were tested for the frequencies of
spontaneous conversions at the tryptophan locus and rever-
tants at the isoleucine locus. Cells from a culture with a low
frequency of spontaneous gene conversion and a low back
mutation (reversion of point mutation) frequency were
grown in liquid medium at 28°C until they reached a
stationary phase. S. cerevisiae cells were sedimented and
resuspended in sterile potassium phosphate buffer (0.1M;
pH7.4) to obtain a final concentration of 2× 108 cells/mL.
As a mutagenic compound, ethyl methanesulfonate (EMS;
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1mg/mL) was added and incubated with the cell suspension,
the potassium phosphate buffer, and HEG at final concentra-
tions of 1.5 and 3.0mg/mL. The mixture was incubated with
stirring for 2 h at 37°C. The cells were then plated on
complete and selective media to evaluate survival, tryptophan
convertants, and isoleucine revertants. The experiments were
performed in triplicate.
2.7. Anti-Inflammatory Activity Assessment by Hyaluronidase
Enzyme Inhibition. The anti-inflammatory potential of
HEG was evaluated indirectly by examining its inhibition of
hyaluronidase enzyme activity according to the method
described by Silva et al. [32]. The reaction mixture consisted
of 50μL of HEG and 50μL (350 units) of hyaluronidase (type
IV-S; bovine testes, Sigma, St. Louis, MO, USA), which was
incubated at 37°C for 20min. Next, 1.2μL of calcium chloride
(2.5× 10−3M) was added, and the mixture was incubated at
37°C for 20min to activate the enzyme. As a substrate,
500μL of hyaluronic acid sodium salt (0.1M) was added.
The mixture was incubated at 37°C for 40min, 100μL of
potassium tetraborate (0.8M) was then added, and the
mixture was incubated at 100°C for 3min. After cooling
the solution, 3mL of p-dimethylaminobenzaldehyde was
added, and the mixture was incubated at 37°C for 20min.
Its absorbance was then measured at 585nm in a spectropho-
tometer (PG Instruments Limited, Leicestershire, UK).
Distilled water was used as a control. The experiments
were performed in triplicate. The percent inhibition of
enzyme activity relative to the control was calculated using
the following:
Inhibition of hyaluronidase activity % =
Abscontrol −Abssample
Abscontrol
× 10
5
2.8. Antimicrobial Activity. The microorganisms used in this
study are listed in Table 1. The clinical microorganisms were
isolated from biological fluids collected at the Hospital
Center and were identified at the Laboratory of Microbiology
of the School of Higher Agricultural Education of Bragança
(Escola Superior Agrária de Bragança (ESA)), and reference
strains were obtained from the American Type Culture
Collection (ATCC) (LGC Standards SLU, Barcelona, Spain).
Prior to experimental use, the isolates were maintained in
Muller-Hinton medium containing 20% glycerol at −70°C.
The inoculum for the assays was prepared by dilution of a cell
mass in 0.85% NaCl solution to 0.5 on the McFarland scale
and confirmed by spectrophotometry at 580 and 640nm
for bacteria and yeast, respectively. For antimicrobial assays,
microorganism suspensions were diluted to 104 colony-
forming units (CFU)/mL according to the method described
by Silva et al. [32]. Nutrient broth (NB) or yeast extract-
peptone-dextrose (YPD) was used in microplates (96 wells).
The HEG was diluted in dimethyl sulfoxide (DMSO) and
transferred to the first well of the plate; serial dilutions were
then performed. The inoculum was added to all wells, and
the plates were incubated at 37°C for 24 h (bacteria) or at
25°C for 48h (yeast). As positive controls, the antibiotic gen-
tamicin and the antifungal amphotericin B were used. In
addition, media controls were conducted with and without
inocula, and DMSO alone was used as a solvent control in
inoculated medium. Antimicrobial activity was detected
by the addition of 20μL of 2,3,5-triphenyl-2H-tetrazolium
chloride (TTC) solution (5mg/mL). The minimal inhibitory
concentration (MIC) was defined as the lowest concentration
of HEG that inhibited visible growth of the microorganisms
as indicated by TTC staining of living cells.
To determine the minimum bactericidal concentration
(MBC) and minimum fungicidal concentration (MFC),
Table 1: Microorganisms used in the present study to test the antimicrobial activity of HEG from M. q. anthidioides.
Microorganism Reference Origin
Staphylococcus aureus ATCC 6538™ Reference culture
Methicillin-resistant S. aureus ESA 175 Pus
Methicillin-resistant S. aureus ESA 159 Expectoration
Enterococcus faecalis ATCC 43300™ Reference culture
Vancomycin-resistant E. faecalis ESA 201 Urine
Vancomycin-resistant E. faecalis ESA 361 Rectal swabs
Escherichia coli ATCC 29998™ Reference culture
Cephalosporin-resistant E. coli ESA 37 Urine
Cephalosporin-resistant E. coli ESA 54 Hemoculture
Pseudomonas aeruginosa ATCC 15442™ Reference culture
Imipenem-resistant P. aeruginosa ESA 22 Expectoration
Imipenem-resistant P. aeruginosa ESA 23 Gingival exudates
Cryptococcus neoformans ATCC 32264 Reference culture
Amphotericin B-resistant C. neoformans ESA 211 Blood
Amphotericin B-resistant C. neoformans ESA 105 Skin biopsy
Candida albicans ATCC 10231™ Reference culture
Amphotericin B-resistant C. albicans ESA 100 Feces
Amphotericin B-resistant C. albicans ESA 97 Urine
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20μL samples was collected from the last well where growth
was observed and from each well that did not show a change
in staining, and the samples were plated on NB or YPD and
incubated at 37°C for 24 h (bacteria) or at 25°C for 48 h
(yeast). The MBC or MFC was defined as the lowest concen-
tration that did not result in growth (<10CFU/plate) after
cultivation. The results are expressed as mg/mL, and the
experiments were performed in triplicate.
2.9. Statistical Analyses. The data are expressed as the
mean± standard error of the mean (SEM) and were evalu-
ated by ANOVA followed by the Dunnett’s test using
GraphPad Prism Software version 5.0 (GraphPad Software
Inc., San Diego, CA, USA). The results were considered
significant when P < 0 05.
3. Results
3.1. Chemical Composition. The total concentrations of
phenolic compounds and flavonoids present in HEG were
118.7± 2.8mg GAE/g extract and 25.4± 2.8mg QE/g extract,
respectively.
Peaks 1, 2, 4, 5, 6, 7, 9, 11, and 12 showed similar UV
spectra and MS/MS fragments. The UV absorbance of the
compounds was centered at approximately 300 nm, and the
observed variations were compatible with the presence of
different moieties (Figure 1, Table 2). All of these compounds
exhibited a central hexose with two or three galloyl,
cinnamoyl, or coumaroyl groups. Certain key fragments
supported putative identities of the peaks, such as m/z 169
(C7H5O5)
−, related to gallic acid, observed in compounds 2,
3, 4, 5, 6, 9, and 12; m/z 313 (C13H13O9)
−, related to a
galloyl-hexoside fragment, detected in compounds 1, 2, 4, 6,
9, and 12; and m/z 465 (C20H17O13)
−, related to a digalloyl-
hexoside moiety, observed in compounds 4 and 6. Other
fragments yielded less information, as in the case of m/z
265 (C13H13O6)
−, m/z 235 (C12H11O5)
−, and m/z 205
(C11H9O4)
− in compound 2 or m/z 145 (C9H5O2)
− in
compounds 7 and 8; these fragments are likely the result
of substitutions at specific positions of the hexose.
Unfortunately, the determination of these sites was not
possible due to a lack of information in the literature
or a limited access to standards. Thus, compounds were iden-
tified as coumaroyl-galloyl-hexoside derivatives (1 and 2),
digalloyl-coumaroyl-hexoside (4), cinnamoyl-galloyl-hexoside
(5), digalloyl-cinnamoyl-hexoside (6), dicoumaroyl-hexoside
(7), dicoumaroyl-galloyl-hexoside (9), cinnamoyl-coumaroyl-
hexoside (11), and cinnamoyl-coumaroyl-galloyl-hexoside
(12); compounds of this class were also isolated from the
geopropolis of M. subnitida [1].
The HEG also contained three observed flavanones
(peaks 3, 8, and 10). They were characterized based on their
UV spectra, high-resolution mass, and fragments such as
aromadendrin, naringenin, and methyl aromadendrin,
which were previously reported in the geopropolis of
Melipona ssp. [1, 16].
The final characterized peaks were detected at the end of
the chromatogram (peaks 14, 15, 16, 17, 18, 19, and 20;
Figure 1), implying that they were apolar compounds. These
peaks did not absorb in the UV-monitored range, and their
molecular formulae suggest diterpene (peaks 14 and 15)
and triterpene (peaks 16, 17, and 18) derivatives. Although
these chemical classes are very common in propolis and
geopropolis [24, 25], no more information could be obtained
due to a lack of fragmentation and the large number of
possible skeletons.
Compounds 19 (C24H38O3) and 20 (C24H36O3) showed
similar formulae, differing by only two hydrogens; both
showed only one fragment that was related to CO2 loss,
suggesting the presence of carboxylic acid in the structure.
However, no compatible plant metabolites were found in
the literature.
3.2. Antioxidant Activity
3.2.1. DPPH• and ABTS•+ Free Radical Scavenging. The HEG
displayed relevant antioxidant action in the direct scavenging
of the free radicals DPPH• and ABTS•+. In the DPPH• assay,
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Figure 1: Base peak chromatogram of M. q. anthidioides geopropolis extract. Peaks 1 to 20 are identified in Table 1.
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HEG inhibited 50% of the free radicals (IC50) at a
concentration of 28.9± 1.3μg/mL, an activity 1.7 times lower
than that of the antioxidant BHT (IC50 = 16.9± 5.2μg/mL)
(Figure 2(a)). In the ABTS•+ assay, the HEG showed an
IC50 of 9.5± 0.8μg/mL, similar to the synthetic antioxidant
BHT (IC50 = 8.1± 0.7μg/mL); however, HEG showed five
times less activity than the standard antioxidant ascorbic acid
(IC50 = 1.8± 0.05μg/mL) (Figure 2(b)).
3.2.2. Hemolytic Activity and Inhibition of Oxidative
Hemolysis. Human erythrocytes incubated with the highest
concentrations (75μg/mL) of ascorbic acid (Figure 3(a))
or HEG (Figure 3(b)) did not show hemolysis, indicating
that these compounds did not promote changes in this
cellular model.
In the presence of the oxidizing agent AAPH, HEG
protected the erythrocytes against oxidative hemolysis
throughout the experimental period (Figure 3(b)). After
240min, HEG inhibited 80.9± 5.6% of oxidative hemolysis
at 75μg/mL, demonstrating superior antihemolytic action
relative to that of ascorbic acid, which protected 67.6± 4.5%
of erythrocytes at the same concentration (Figure 3(a)).
3.2.3. Inhibition of MDA Production. The ability of the
extract to inhibit lipid peroxidation was assessed by measur-
ing MDA levels. After 240min, 75μg/mL HEG was able to
reduce MDA levels by 81.2± 10%, whereas the standard
antioxidant ascorbic acid inhibited 65.5± 7.7% of MDA
production at the same concentration (Figure 4).
3.3. Antimutagenic Activity. The HEG of M. q. anthidioides
showed an antimutagenic effect on S. cerevisiae cells
incubated with the mutagen EMS. HEG reduced the survival
of S. cerevisiae D7 by approximately 50% (Figure 5(a)),
Table 2: Compounds identified from Melipona quadrifasciata anthidioides geopropolis extract by HPLC-DAD-ESI-qTOF-MS/MS.
Peak RT (min) UV (nm) MS (m/z)
Molecular
formula
Error
(ppm)
MS/MS (m/z) Identification
1 24 289 and 309 477.1053 C22H22O12 2.9 313 (C13H13O9)
−, 271 (C11H11O8)
−, 169 (C7H5O5)
− Coumaroyl-
galloyl-hexoside
2 24.7 289 and 309 477.1040 C22H22O12 0.5
313 (C13H13O9)
−, 265 (C13H13O6)
−, 235 (C12H11O5)
−,
205 (C11H9O4)
−, 169 (C7H5O5)
−
Coumaroyl-
galloyl-hexoside
3 25.1 289 287.0565 C15H12O6 1.6 259 (C14H11O5)
−, 177 (C10H9O3)
− Aromadendrin
4 26 286 and 308 629.1166 C29H26O16 3.1
465 (C20H17O13)
−, 459 (C22H19O11)
−, 313
(C13H13O9)
−, 271 (C11H11O8)
−, 169 (C7H5O5)
−
Digalloyl-
coumaroyl-
hexoside
5 30.8 280 461.1113 C22H22O11 3.7 211 (C9H7O6)
−, 169 (C7H5O5)
−, 161 (C10H9O2)
− Cinnamoyl-
galloyl-hexoside
6 31.9 280 613.1216 C29H26O15 2.2
465 (C20H17O13)
−, 313 (C13H13O9)
−, 271 (C11H11O8)
−,
211 (C9H7O6)
−, 169 (C7H5O5)
−
Digalloyl-
cinnamoyl-
hexoside
7 32.4 299 and 311 471.1324 C24H24O10 4.3
325 (C15H17O8)
−, 307 (C15H15O7)
−, 265 (C13H13O6)
−,
163 (C9H7O3)
−, 145 (C9H5O2)
−
Dicoumaroyl-
hexoside
8 32.9 284 271.0622 C15H12O5 3.2 — Naringenin
9 34.3 290 and 311 623.1428 C31H28O14 2.2
459 (C22H19O11)
−, 313 (C13H13O9)
−, 271 (C11H11O8)
−,
211 (C9H7O6)
−, 169 (C7H5O5)
−,163 (C9H7O3)
−
Dicoumaroyl-
galloyl-hexoside
10 35.2 290 301.0731 C16H14O6 2.8
273 (C15H13O5)
−, 240 (C14H8O4)
−, 179 (C8H3O5)
−, 165
(C8H5O4)
−
Methyl
aromadendrin
11 37.9 285 and 310 455.1353 C24H24O9 1.2 163 (C9H7O3)
−, 145 (C9H5O2)
−
Cinnamoyl-
coumaroyl-
hexoside
12 38.8 285 and 310 607.1455 C31H28O13 2.7
461 (C22H21O11)
−, 443 (C22H19O10)
−, 313
(C13H13O9)
−, 271 (C11H11O8)
−, 211 (C9H7O6)
−,
169 (C7H5O5)
−
Cinnamoyl-
coumaroyl-
galloyl-hexoside
13 42.1 295 421.1290 C24H22O7 0.9 — Unknown
14 45.7 — 319.2272 C20H32O3 3.4 — Diterpene
15 46.3 — 319.2270 C20H32O3 0.9 — Diterpene
16 54 — 471.3475 C30H48O4 0.8 — Triterpene
17 55.3 — 471.3471 C30H48O4 3.3 — Triterpene
18 55.5 — 469.3314 C30H46O4 3.0 — Triterpene
19 58.7 — 373.2736 C24H38O3 2.9 329 (C23H37O)
− Unknown
20 64 — 371.2583 C24H36O3 3.0 327 (C23H35O)
− Unknown
RT: retention time; − indicates nonobserved/detected means.
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possibly because of its fungicidal action, and showed an anti-
mutagenic effect by inhibiting the DNA damage promoted by
EMS. The HEG reduced gene conversion frequencies by 30.7
± 4.8% and 41.5± 1.7% at concentrations of 1.5 and 3.0mg/
mL, respectively (Figure 5(b)). In addition, HEG reduced
the number of mutant colonies by 79.4± 0.8% at 1.5mg/mL
and by 89.3± 0.5% at 3.0mg/mL (Figure 5(c)).
3.4. Anti-Inflammatory Activity. The anti-inflammatory
activity of HEG was evaluated by testing its ability to inhibit
hyaluronidase enzyme activity in the presence of its sub-
strate, hyaluronic acid sodium salt. The extract showed a
concentration-dependent profile, inhibiting 44.7± 2.4% of
hyaluronidase activity at 75mg/mL (Figure 6).
3.5. Antimicrobial Activity. HEG showed antimicrobial
activity against all of the tested microorganisms, including
antimicrobial drug-resistant strains (Table 3). Gram-positive
bacteria were more sensitive to HEG than were gram-
negative species. The most sensitive microorganism was
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Figure 2: Antioxidant activity, as shown by scavenging of the free radicals (a) DPPH• and (b) ABTS•+ by the ascorbic acid and BHT controls
and by the M. q. anthidioides geopropolis extract (0.1–200μg/mL).
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Figure 3: Inhibition of oxidative hemolysis in human erythrocytes incubated with (a) ascorbic acid and (b) HEG (5–125μg/mL) in the
presence of the oxidizing agent AAPH for 240min. ∗Statistically significant results (P < 0 05) compared to those of the AAPH control
group at the same time point.
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Staphylococcus aureus ATCC 6538, which showed an MIC of
5.16± 0.22mg/mL and an MBC of 7.33± 0.16mg/mL. The
strain with the greatest resistance was the gram-negative
bacteriumPseudomonas aeruginosaESA23, which is resistant
to imipenemandoriginated fromgingival exudate inahospital
setting; it showed anMIC of 12.75± 0.28mg/mL and anMBC
of 16.41± 0.36mg/mL.
HEG also exhibited antifungal activity against all of the
tested yeasts, including reference strains and those of hospital
origin. The strain most sensitive to the action of HEG was
Cryptococcus neoformans ATCC 32264, and the most
resistant strain was Candida albicans ESA 97, which is
resistant to amphotericin B and is of hospital origin.
4. Discussion
The literature contains few scientific studies related to the
chemical composition and pharmacological properties of
geopropolis, an apicultural product with great pharmacolog-
ical potential. In folk medicine, it is prescribed for the
treatment of digestive, respiratory, and visual problems [33]
and as an antiseptic [18]. These activities are related to the
chemical composition of geopropolis, which is dependent
on the local flora, the producing bee species, and the type of
soil found in the region of geopropolis production [1, 3].
Phenolic heterosides, flavanones, and terpenoids were
observed in the HEG; these compounds are frequently
detected in Apis mellifera propolis [34, 35] but have not often
been described forMelipona geopropolis. An important find-
ing was the presence of di- and trigalloyl and phenylpropanyl
heteroside derivatives, which are rarely reported in the
literature. Despite the paucity of reports, this class of
compounds occurs in the kino of Eucalyptus spp. [36, 37], a
common plant in the region where the geopropolis was
collected. This observation may provide a clue about the
source of raw material for the production of geopropolis by
Melipona spp.
Other information about the origin of geopropolis came
from a study performed by Sawaya et al. [38] with the sting-
less bee Tetragonisca angustula that reported compounds 19
and 20 in the propolis of this species and in the flowers and
leaves of Schinus terebinthifolius. We analyzed the methano-
lic extract of the leaves of S. terebinthifolius from the same
region where the geopropolis was collected and confirmed
the presence of compound 20 (see Supplementary Material
available online at https://doi.org/10.1155/2017/8320804).
We conclude that M. q. anthidioides uses vegetal material
from S. terebinthifolius to produce geopropolis. Flavanones
and terpenes, the other two classes of identified compounds,
are also normally present in apicultural plants [39–41],
suggesting that Melipona spp. can use the same plants that
Apis spp. use to produce propolis.
The phenolic compounds are described as important
antioxidant agents [7, 26, 30], and the content present in
the HEG was approximately two times more than that pres-
ent in geopropolis from other species of bees, as Melipona
subnitida [1] and Melipona fasciculata [6]. Among the phe-
nolic compounds identified in the HEG, the flavonoids
methyl aromadendrin [42] and naringenin [43] are described
as having antioxidant activities. In this study, HEG was able
to scavenge the free radicals DPPH• and ABTS•+, showing
results similar to those presented by the geopropolis of
M. subnitida [1] and higher compared to those by the
geopropolis of the speciesMelipona interrupta andMelipona
seminigra [16].
Moreover, HEG protected human erythrocytes against
damage generated by the oxidizing agent AAPH, resulting
in lower levels of both oxidative hemolysis and malondialde-
hyde (as a marker of lipid peroxidation). Flavonoids inhibit
peroxyl radicals via the donation of hydrogen atoms, a
process enabled by the presence of a dihydroxylated B ring
in their structures [44]. Peroxyl radicals are involved in the
lipid peroxidation process, which creates a number of degra-
dation products, such as the aldehydes 4-hydroxy-2-nonenal,
2-propenal, and malondialdehyde [45]. Naringenin, one of
the flavonoids identified in HEG, has been described as
modulating the activity of the enzymes superoxide dismut-
ase, glutathione peroxidase, and catalase, in addition to
protecting the cell membrane against the lipid peroxidation
process by inhibiting the production of malondialdehyde
and increasing the content of thiol-SH groups [43]. In turn,
diterpenes promote the scavenging of free radicals, which
results in the inhibition of lipid peroxidation [46, 47].
Lipid peroxidation resulting from elevated cellular oxida-
tive stress is capable of promoting damage to proteins
and nucleic acids, which may constitute the first steps of
mutagenesis and carcinogenesis [48, 49]. With this per-
spective, after confirming the antioxidant activity of HEG
from M. q. anthidioides, its antimutagenic properties were
investigated. The HEG minimized the damage induced by
the EMS alkylating agent, which induces random mutations
in DNA by nucleotide substitution [31]. The antimutagenic
activity of the HEG was similar to that of the geopropolis
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Figure 4: Malondialdehyde concentration (MDA) in nM/mL
after incubation of erythrocytes for 240min with ascorbic
acid or HEG (5–125μg/mL) in the presence of the oxidizing agent
AAPH. ∗Statistically significant results (P < 0 05) compared to
those of the AAPH control group.
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extract of Melipona orbignyi, regarding the reduction of
mutant colonies; however, it was more effective against the
gene conversion [7].
Living organisms have mutation repair mechanisms;
however, they are often unable to correct all of the changes
that occur, leaving the cell vulnerable to the development of
problems related to DNA alterations [50]. Certain changes
in the genetic material of cells are related to the development
of cancer [51, 52]. Thus, products with antimutagenic
activities can aid in preventing various types of cancers.
In addition to its antioxidant and antimutagenic
activities, there are reports in the literature about the anti-
inflammatory action of geopropolis, both in vitro and
in vivo, via modulation of the main inflammatory mediators
[12, 14]. In this study, HEG showed anti-inflammatory
action in its inhibition of hyaluronic acid degradation by
the hyaluronidase enzyme. Hyaluronic acid is a polysaccha-
ride found primarily in the extracellular and pericellular
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Figure 5: S. cerevisiae yeast cells (D7 diploid strain of ATCC 201137) incubated with HEG (1.5 and 3.0mg/mL) and the mutagen
EMS. (a) Survival percentage, (b) gene conversion, and (c) mutant colonies are shown. ∗∗∗P < 0 0001 compared to the control.
###P < 0 0001 compared to the EMS control.
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matrix as a component of soft connective tissues [53],
where it has an important role in tissue renewal [32].
The degradation of hyaluronic acid by hyaluronidase
results in tissue permeability [54], bone loss, inflammation,
and pain [31, 54].
The inhibition of hyaluronidase activity by HEG may
be related to the presence of flavonoids in its composition,
as they have been described as reducing hyaluronidase
activity by binding to the enzyme and promoting struc-
tural alterations by means of electrostatic forces and
hydrophobic interactions [55]. In addition, the flavonoids
identified in HEG, naringenin and 7-O-methylaromaden-
drin, reportedly inhibit the activity of the cyclooxygenase
1 enzyme, and aromadendrin inhibits the activity of
xanthine oxidase [56]; these enzymes are directly related
to inflammatory processes.
Another important pharmacological activity exhibited by
HEG was its antimicrobial action against both reference and
clinical strains. HEG promoted the death of all of the tested
gram-positive bacteria, gram-negative bacteria, and yeasts.
Previous studies by Kujumgiev et al. [24] and Velikova
et al. [25] described the antimicrobial potential of propolis
from M. q. anthidioides; however, this is the first report to
show that the geopropolis of this bee subspecies can combat
pathogenic microorganisms.
The identification of new compounds with antimicrobial
action has aroused the interest of the pharmaceutical indus-
try, especially because many strains of microorganisms have
become resistant to currently available antimicrobial drugs,
thereby resulting in high morbidity and mortality rates,
especially among nosocomial infections [57, 58]. Among
the main mechanisms of resistance are the elimination of
antibiotics by efflux pumps present in the cell wall of micro-
organisms [59, 60] and the degradation of antibiotics by
specific enzymes [61].
Natural products represent a good source for the
discovery of bioactive compounds with high antimicrobial
activity, especially considering the complexity of the mole-
cules present in these bioproducts [62]. The antimicrobial
properties of geopropolis from other bee species have been
described in other studies with Melipona fasciculata [2, 63],
Melipona orbignyi [7], Melipona scutellaris [10, 11], and
Melipona mondury [64], as well as the subspecies Melipona
compressipes fasciculate [65].
Table 3: MIC and MBC/MFC values for HEG from M. q. anthidioides.
(a)
Microorganisms
HEG (mg/mL) Gentamicin (μg/mL)
MIC MBC MIC MBC
Gram-positive bacteria
Staphylococcus aureus ATCC 6538 5.16± 0.22 7.33± 0.16 1.66± 0.16 2.0± 0.28
Methicillin-resistant S. aureus ESA 175 5.75± 0.14 7.83± 0.16 1.83± 0.16 2.66± 0.16
Methicillin-resistant S. aureus ESA 159 6.25± 0.14 8.08± 0.22 2.0± 0.28 2.50± 0.28
Enterococcus faecalis ATCC 43300 6.75± 0.14 8.75± 0.25 2.16± 0.16 2.83± 0.30
Vancomycin-resistant E. faecalis ESA 201 7.33± 0.83 9.50± 0.28 2.33± 0.16 3.25± 0.14
Vancomycin-resistant E. faecalis ESA 361 7.58± 0.30 9.91± 0.54 2.66± 0.16 3.33± 0.16
Gram-negative bacteria
Escherichia coli ATCC 29998 9.66± 0.44 13.0± 0.14 4.08± 0.08 4.58± 0.30
Cephalosporin-resistant E. coli ESA 37 10.25± 0.52 13.16± 0.44 4.66± 0.16 4.66± 0.22
Cephalosporin-resistant E. coli ESA 54 10.25± 0.25 13.33± 0.36 4.41± 0.08 4.91± 0.08
Pseudomonas aeruginosa ATCC 15442 11.91± 0.36 15.41± 0.36 4.75± 0.14 5.0± 0.28
Imipenem-resistant P. aeruginosa ESA 22 12.16± 0.60 15.41± 0.30 5.66± 0.16 6.61± 0.16
Imipenem-resistant P. aeruginosa ESA 23 12.75± 0.28 16.41± 0.36 6.66± 0.33 6.50± 0.28
(b)
Microorganisms
HEG (mg/mL) Amphotericin B (μg/mL)
MIC MFC MIC MFC
Fungi
Cryptococcus neoformans ATCC 32264 18.08± 0.36 23.0± 0.14 0.55± 0.02 0.86± 0.07
Amphotericin B-resistant C. neoformans ESA 211 18.58± 0.71 24.08± 0.46 0.61± 0.06 1.25± 0.14
Amphotericin B-resistant C. neoformans ESA105 19.08± 0.82 24.25± 0.25 0.63± 0.01 1.66± 0.22
Candida albicans ATCC 10231 20.5± 0.28 28.25± 0.87 0.71± 0.04 0.91± 0.16
Amphotericin B-resistant C. albicans ESA 100 21.41± 0.54 29.33± 0.60 0.81± 0.04 1.66± 0.08
Amphotericin B-resistant C. albicans ESA 97 21.83± 0.44 31.08± 0.68 0.91± 0.01 1.75± 0.14
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Among the chemical compounds described as responsi-
ble for the antimicrobial activity of natural products are
the flavonoids [66, 67]. In bacteria, they are capable of
inhibiting DNA gyrase [68], damaging cell membranes by
reducing their fluidity [69] and decreasing microbial energy
metabolism [66]; these mechanisms are responsible for their
antibacterial effects. In addition to these, diterpenes are also
described as having antimicrobial activity, as they easily
penetrate the cell membranes of microorganisms and create
pores that result in the loss of intracellular contents [44].
In this context, this study is the first to report the
chemical composition and pharmacological activities of the
geopropolis extract of M. q. anthidioides, a natural product
of apicultural origin that has great potential to be used in
the prevention and treatment of several diseases related to
oxidative stress, mutagenesis, inflammatory processes, and
microbial infections.
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